世界品牌莫干山大会|以岭药业被授予“品牌创新先锋企业”称号

Group 1 - The 2025 World Brand Moganshan Conference was held in Deqing, Zhejiang, where Yiling Pharmaceutical was awarded the title of "Brand Innovation Pioneer" [1] - Yiling Pharmaceutical is recognized as a leading innovative traditional Chinese medicine (TCM) company, focusing on overseas brand development with the core philosophy of "inheritance and innovation" [3] - The company has developed 17 innovative patented TCM products targeting major diseases such as cardiovascular diseases, respiratory diseases, tumors, diabetes, neurological diseases, and urinary system diseases [3] Group 2 - Yiling Pharmaceutical's research shows that Tongxinluo capsules can reduce the risk of acute myocardial infarction death by 30% and the risk of recurrence by 74% [4] - The company has published its research findings in prestigious international medical journals, enhancing its credibility and market trust [4] - The innovative TCM product Bazibu Shen capsules has been shown to effectively intervene in 10 internationally recognized aging mechanisms, contributing positively to addressing the challenges of population aging [4] Group 3 - The report highlights Yiling Pharmaceutical's efforts to align TCM efficacy with international standards through evidence-based medicine, enhancing the global recognition of TCM [5] - The company utilizes modern medical language to interpret traditional wisdom, thereby increasing TCM's influence in the global health sector [5] - This is the fourth consecutive year that the report on the overseas communication capabilities of Chinese enterprises has been published, analyzing data from approximately 3,000 overseas mainstream media and social media platforms [5]